Condensed Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development	$ 5,225	$ 4,513	$ 19,020	$ 9,725
General and administrative	3,309	3,210	10,094	7,635
Total operating expenses	8,534	7,723	29,114	17,360
Loss from operations	(8,534)	(7,723)	(29,114)	(17,360)
Other income (expenses):
Other income		6		506
Interest income (expense), net	1	(3)	4	(5)
Net loss	(8,533)	(7,720)	(29,110)	(16,859)
Deemed dividend arising from warrant modification	(622)		(622)
Net loss attributable to common stockholders	$ (9,155)	$ (7,720)	$ (29,732)	$ (16,859)
Per share information:
Net loss per share of common stock, Basic	$ (0.75)	$ (0.65)	$ (2.45)	$ (1.49)
Net loss per share of common stock, Diluted	$ (0.75)	$ (0.65)	$ (2.45)	$ (1.49)
Weighted-average common shares outstanding, Basic	12,127,501	11,934,491	12,125,947	11,348,856
Weighted-average common shares outstanding, Diluted	12,127,501	11,934,491	12,125,947	11,348,856